DISCOUNT-ZERTIFIKAT - MODERNA Share Price

Certificat

DE000SW20W93

Market Closed - Deutsche Boerse AG 01:11:14 18/05/2024 am IST
63.09 EUR -0.02% Intraday chart for DISCOUNT-ZERTIFIKAT - MODERNA
Current month-0.55%
1 month+0.54%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
17/24/17 63.09 -0.02%
16/24/16 63.1 +0.22%
15/24/15 62.96 -0.52%
14/24/14 63.29 -0.24%
13/24/13 63.44 +0.06%

Delayed Quote Deutsche Boerse AG

Last update May 18, 2024 at 01:11 am IST

More quotes

Static data

Product typeDiscount-Zertifikate
Buy / SellCALL
Underlying MODERNA, INC.
IssuerLogo Issuer Société Générale Société Générale
WKN SW20W9
ISINDE000SW20W93
Date issued 01/09/2023
Maturity 20/09/2024 (125 Days)
Parity 1 : 1
Emission price 57.54
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 63.81
Lowest since issue 50.14

Company Profile

Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for cancer, infectious, autoimmune and cardiovascular diseases. Net sales break down by type of revenue as follows: - revenue from product sales (95.7%) ; - revenues from grants (4%); - revenues from collaboration agreements (0.3%). At the end of 2021, the group possessed a portfolio of 15 products in clinical development, of which 3 in phase III, 8 in phase II and 4 in phase I, and 12 products in preclinical development. Net sales are distributed geographically as follows: the United States (33.4%), Europe (37.1%) and other (29.5%).
Sector
-
More about the company

Ratings for Moderna, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Moderna, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
132.9 USD
Average target price
138.5 USD
Spread / Average Target
+4.22%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW